ActualitésAssisté par IA

WHO Prioritizes 17 Pathogens for Urgent Vaccine Development

WHO lists 17 pathogens as top vaccine R&D priorities, addressing global health burdens and resistance threats.

Mrudula Kulkarni
Par Mrudula Kulkarni
Rédacteur en chef - Pharma Now
6 nov. 2024Updated Jun 26, 2025 · 2 min de lecture
WHO Prioritizes 17 Pathogens for Urgent Vaccine Development
https://www.immerse.education/study-tips/biology/what-are-pathogens/
Journalisme assisté par IA
Reviewed by Mrudula Kulkarni, Rédacteur en chef - Pharma Now

The World Health Organization (WHO) has identified 17 pathogens that cause significant diseases globally as top priorities for new vaccine development, as reported in a recent study in eBioMedicine. These include HIV, malaria, and tuberculosis, which collectively account for millions of deaths each year, as well as antimicrobial-resistant threats like Group A streptococcus and Klebsiella pneumoniae. This prioritization aims to guide equitable vaccine R&D to tackle diseases that heavily impact health systems and vulnerable communities.

Using global and regional data, WHO collaborated with experts to rank pathogens based on disease burden, resistance potential, and socioeconomic effects. This list is part of WHO's broader goal to strengthen immunization, particularly in low- and middle-income countries, aligning with the Immunization Agenda 2030 to ensure accessible vaccines worldwide. This study also complements WHO’s R&D efforts for epidemic preparedness by addressing endemic pathogens that pose ongoing public health challenges.

Mrudula Kulkarni
Written by
Mrudula Kulkarni
Rédacteur en chef - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Chargement de la discussion…

Plus dans Pharma News

Tous les articles →